Angela Minassian reflects on what the malaria community can learn from the 'supercharged' COVID vaccine effort.
Angela Minassian, MD, is the Chief Investigator and clinical lead on the blood-stage and transmission blocking malaria vaccine programs at the University of Oxford.
